Lipoxygenase: An Emerging Target for Stroke Therapy

Author(s): Klaus van Leyen

Journal Name: CNS & Neurological Disorders - Drug Targets
Formerly Current Drug Targets - CNS & Neurological Disorders

Volume 12 , Issue 2 , 2013

Become EABM
Become Reviewer
Call for Editor


Neuroprotection as approach to stroke therapy has recently seen a revival of sorts, fueled in part by the continuing necessity to improve acute stroke care, and in part by the identification of novel drug targets. 12/15- Lipoxygenase (12/15-LOX), one of the key enzymes of the arachidonic acid cascade, contributes to both neuronal cell death and vascular injury. Inhibition of 12/15-LOX may thus provide multifactorial protection against ischemic injury. Targeting 12/15-LOX and related eicosanoid pathways is the subject of this brief review.

Keywords: Ischemic stroke, neuroprotection, oxidative stress, eicosanoid, lipoxygenase, arachidonic acid cascade.

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 02 April, 2013
Page: [191 - 199]
Pages: 9
DOI: 10.2174/18715273112119990053

Article Metrics

PDF: 60